Clinical

Dataset Information

A Clinical Study to Evaluate the Safety and Efficacy of Anti-CEA CAR-T Cells in the Treatment of Postoperative Minimal Residual Lesions in Colorectal Cancer Patients With Liver Metastases


ABSTRACT: Interventions: Single Group Dose Escalation Assignment:CAR-T cells infusion Primary outcome(s): Security (Incidence and severity of adverse events);Effectiveness (minimal residual disease);Efficacy (recurrence-free survival) Study Design: Single arm

DISEASE(S): Colorectal Cancer

PROVIDER: 36953 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR